- Home
- NGEN vs OZ Comparison
NGEN vs OZ Comparison
Compare NGEN & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NGEN | OZ |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | Canada | United States |
| Employees | 9 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.5M | 179.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NGEN | OZ |
|---|---|---|
| Price | $1.61 | $45.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 739.3K | 5.6K |
| Earning Date | 04-02-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,187,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 243.44 |
| 52 Week Low | $1.59 | $44.25 |
| 52 Week High | $5.93 | $69.00 |
Technical Indicators
Market Signals| Indicator | NGEN | OZ |
|---|---|---|
| Relative Strength Index (RSI) | 32.53 | 46.89 |
| Support Level | N/A | $44.30 |
| Resistance Level | $2.22 | $45.99 |
| Average True Range (ATR) | 0.11 | 0.61 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 2.32 | 59.30 |
Price Performance
Historical ComparisonAbout NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset. The majority of the revenue is earn from mixed-use segment.